NU58DP007462
Cooperative Agreement
Overview
Grant Description
The DC Million Hearts Program: A strategic approach to preventing and controlling cardiovascular disease - Heart disease and stroke are the 1st and 5th leading causes of death in the District of Columbia (District) (Vital Records Division, 2021). Combined, they accounted for almost 1,400 deaths in 2021.
The two main reasons individuals develop heart disease and stroke are hypertension and high cholesterol, which are common, preventable, and can lead to death. Behavioral Risk Factor Surveillance Survey data show that 155,675 (27.9%) adult District residents have hypertension and 143,131 (30.6%) have high cholesterol (DC Health, 2021).
Disparities in these prevalence rates persist by race, place of residence, and socioeconomic factors. Data show that District residents who are Black/African American, with lower educational attainment, and have lower income levels experience higher rates of hypertension and high cholesterol (DC Health, 2021).
DC Health’s Chronic Disease Division (CDD) implements evidence-based, data-informed promising practice strategies to address the most common chronic conditions and risk factors to advance health, wellness, and equity across the District. Our team of chronic disease experts work closely with health systems, community-based organizations, government agencies, and other key partners to ensure that data-driven, evidence-based, and sustainable approaches are utilized to improve heart disease, stroke, and other chronic disease outcomes among all District residents.
Under the previous funding cycle, DC Health’s Million Hearts Program successfully increased the capacity of eight (8) federally qualified health systems (FQHCs) and hospitals and the District Primary Care Association to monitor key clinical indicators for hypertension and blood cholesterol control, formed and leveraged community, clinical, and public health relationships to build and sustain the Million Hearts Learning Collaborative, connected residents to community-based resources and lifestyle change programs, and increased the implementation of clinical quality improvement interventions to improve the prevention and management of hypertension and high cholesterol in federally qualified health centers (FQHCs) and hospitals.
Between 2019-2021, data shows that the program reached an average of 15,135 hypertension patients per year. The program focused efforts on improving data quality of larger health systems in 2022, which accounted for an additional 46,337 hypertension patients reached in 2022.
DC Health intends to leverage successes and lessons learned under the previous funding cycle to further the prevention and management of cardiovascular disease by preventing and controlling high cholesterol and hypertension and addressing social barriers that disproportionately impact District residents at highest risk or burden.
To achieve statewide reach in the prevention and management of heart disease and stroke, the District aims to implement evidence-based and evidence-informed risk reduction strategies by engaging multilectoral partners through the Million Hearts Learning Collaborative, strengthening the clinical team-based care workforce, expanding the use of clinical and social needs bidirectional referral technology, enhancing clinical and social needs data surveillance, reducing programmatic, provider, and individual barriers to evidence-based interventions, improving organizational and individual health literacy, and implementing educational campaigns.
Strategies within this proposal prioritize high burden populations including residents that are 40 years and over, Black/African American and Hispanic, with lower educational attainment, annual income below $50,000, not working (unemployed, retired, and unable to work), and living in Wards 4, 5, 7, and 8.
The two main reasons individuals develop heart disease and stroke are hypertension and high cholesterol, which are common, preventable, and can lead to death. Behavioral Risk Factor Surveillance Survey data show that 155,675 (27.9%) adult District residents have hypertension and 143,131 (30.6%) have high cholesterol (DC Health, 2021).
Disparities in these prevalence rates persist by race, place of residence, and socioeconomic factors. Data show that District residents who are Black/African American, with lower educational attainment, and have lower income levels experience higher rates of hypertension and high cholesterol (DC Health, 2021).
DC Health’s Chronic Disease Division (CDD) implements evidence-based, data-informed promising practice strategies to address the most common chronic conditions and risk factors to advance health, wellness, and equity across the District. Our team of chronic disease experts work closely with health systems, community-based organizations, government agencies, and other key partners to ensure that data-driven, evidence-based, and sustainable approaches are utilized to improve heart disease, stroke, and other chronic disease outcomes among all District residents.
Under the previous funding cycle, DC Health’s Million Hearts Program successfully increased the capacity of eight (8) federally qualified health systems (FQHCs) and hospitals and the District Primary Care Association to monitor key clinical indicators for hypertension and blood cholesterol control, formed and leveraged community, clinical, and public health relationships to build and sustain the Million Hearts Learning Collaborative, connected residents to community-based resources and lifestyle change programs, and increased the implementation of clinical quality improvement interventions to improve the prevention and management of hypertension and high cholesterol in federally qualified health centers (FQHCs) and hospitals.
Between 2019-2021, data shows that the program reached an average of 15,135 hypertension patients per year. The program focused efforts on improving data quality of larger health systems in 2022, which accounted for an additional 46,337 hypertension patients reached in 2022.
DC Health intends to leverage successes and lessons learned under the previous funding cycle to further the prevention and management of cardiovascular disease by preventing and controlling high cholesterol and hypertension and addressing social barriers that disproportionately impact District residents at highest risk or burden.
To achieve statewide reach in the prevention and management of heart disease and stroke, the District aims to implement evidence-based and evidence-informed risk reduction strategies by engaging multilectoral partners through the Million Hearts Learning Collaborative, strengthening the clinical team-based care workforce, expanding the use of clinical and social needs bidirectional referral technology, enhancing clinical and social needs data surveillance, reducing programmatic, provider, and individual barriers to evidence-based interventions, improving organizational and individual health literacy, and implementing educational campaigns.
Strategies within this proposal prioritize high burden populations including residents that are 40 years and over, Black/African American and Hispanic, with lower educational attainment, annual income below $50,000, not working (unemployed, retired, and unable to work), and living in Wards 4, 5, 7, and 8.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
District Of Columbia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 310% from $942,849 to $3,865,681.
Government Of District Of Columbia was awarded
DC Million Hearts Program: Preventing Cardiovascular Disease Disparities
Cooperative Agreement NU58DP007462
worth $3,865,681
from National Center for Chronic Disease Prevention and Health Promotion in June 2023 with work to be completed primarily in District Of Columbia United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.421 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health.
The Cooperative Agreement was awarded through grant opportunity The National Cardiovascular Health Program.
Status
(Ongoing)
Last Modified 7/6/26
Period of Performance
6/30/23
Start Date
6/29/28
End Date
Funding Split
$3.9M
Federal Obligation
$0.0
Non-Federal Obligation
$3.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU58DP007462
Transaction History
Modifications to NU58DP007462
Additional Detail
Award ID FAIN
NU58DP007462
SAI Number
NU58DP007462-3788071002
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CUC0 CDC NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION
Awardee UEI
XUYTN6MMLKE3
Awardee CAGE
3KBH4
Performance District
DC-98
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Health and Human Services (075-0948) | Health care services | Grants, subsidies, and contributions (41.0) | $942,849 | 100% |
Modified: 7/6/26